Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

The heterogeneity of chronic obstructive pulmonary disease (COPD) creates many
diagnostic, prognostic, treatment and management challenges, as the pathogenesis of …

Background Treatment with systemic corticosteroids in patients with acute exacerbations of
chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse …

Purpose Blood eosinophil is a promising biomarker for phenotyping patients with acute
exacerbation of COPD (AECOPD). We aimed to evaluate the prognostic value of eosinophil …

BACKGROUND Eosinophil counts are a promising guide to systemic steroid administration
for chronic obstructive pulmonary disease (COPD). AIM To study the role of peripheral …

Mitogen-activated protein kinase p38 is a key regulator in the inflammation pathway and is
activated in the lungs of chronic obstructive pulmonary disease (COPD) patients …

Treating patients hospitalised with acute exacerbations of chronic obstructive pulmonary
disease (COPD) usually involves administering systemic corticosteroids. The many …

Chronic obstructive pulmonary disease is a prevalent condition in the UK, associated with
high morbidity and mortality. Hospital physicians manage a significant portion of acute …

Background Respiratory viral infection causes chronic obstructive pulmonary disease
(COPD) exacerbations. We previously reported increased bronchial mucosa eosinophil and …

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD
Exacerbation - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …